Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts

The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to an entity list linked to China’s military, but analysts say the move will not deter multinational drug makers from collaborating with Chinese firms due to cost advantages. Jefferies' healthcare research head Cui Cui noted that cost efficiency in China's pharmaceutical manufacturing remains a key factor for multinational companies.